The L3MBTL1 Inhibitor Screening Assay Kit is designed to measure the inhibition of L3MBTL1 binding to its substrate. The key to the kit is the specific binding of the L3MBTL1 MBT domain to the methylated-peptide substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing L3MBTL1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

Q9Y468

L3MBTL1 assay kit, activity assay kit

DMSO >1%, strong acids or bases, ionic detergents, high salt

See data sheet for detailed protocol.

Stable at least 12 months from date of receipt, when stored as directed

Useful for the study of MBT domain binding assays, screening inhibitors, and selectivity profiling

Min, J., et al., Nat Struct Mol Biol.2008 Jan,15(1):114

AlphaScreen^® and AlphaLISA^® are registered trademarks of PerkinElmer, Inc.

Avoid freeze/thaw cycles

Methyl-lysine Reader

Assay Kit